UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Severe cutaneous adverse reactions to drugs

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1996-2011

2017

Volltextzugriff (PDF)

HLA‐B57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans

Allergy (Copenhagen), 2019-11, Vol.74 (11), p.2227-2230

2019

Volltextzugriff (PDF)

Therapeutic management of DRESS: A retrospective study of 38 cases

Journal of the American Academy of Dermatology, 2015-02, Vol.72 (2), p.246-252

2015

Volltextzugriff (PDF)

Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Orphanet journal of rare diseases, 2012-09, Vol.7 (1), p.72-72, Article 72

2012

Volltextzugriff (PDF)

Patch testing in non‐immediate cutaneous adverse drug reactions: value of extemporaneous patch tests

Contact dermatitis, 2017-11, Vol.77 (5), p.297-302

2017

Volltextzugriff (PDF)

Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns

Clinical and experimental allergy, 2019-09, Vol.49 (9), p.1258-1261

2019

Volltextzugriff (PDF)

IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis

Journal of allergy and clinical immunology, 2015-04, Vol.135 (4), p.1067-1070.e9

2015

Volltextzugriff (PDF)

Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study

Journal of the American Academy of Dermatology, 2015-12, Vol.73 (6), p.1006-1012.e8

2015

Volltextzugriff (PDF)

Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis C

Hepatology (Baltimore, Md.), 2014-03, Vol.59 (3), p.1209-1210

2014

Volltextzugriff (PDF)

Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France

Calcified tissue international, 2021-06, Vol.108 (6), p.738-745

2021

Volltextzugriff (PDF)

Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study

Orphanet journal of rare diseases, 2012-09, Vol.7 (1), p.62-62, Article 62

2012

Volltextzugriff (PDF)

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma

Human molecular genetics, 2012-12, Vol.21 (26), p.5397-5405

2012

Volltextzugriff (PDF)

Rare Variations in IL36RN in Severe Adverse Drug Reactions Manifesting as Acute Generalized Exanthematous Pustulosis

Journal of investigative dermatology, 2013-07, Vol.133 (7), p.1904-1907

2013

Volltextzugriff (PDF)

Ischemic myopathy revealing systemic calciphylaxis

Muscle & nerve, 2017-09, Vol.56 (3), p.529-533

2017

Volltextzugriff (PDF)

Prognostic value of histologic features of toxic epidermal necrolysis

Journal of the American Academy of Dermatology, 2013-02, Vol.68 (2), p.e29-e35

2013

Volltextzugriff (PDF)

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France

Orphanet journal of rare diseases, 2011-05, Vol.6 (1), p.18-18, Article 18

2011

Volltextzugriff (PDF)

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

Orphanet journal of rare diseases, 2013-08, Vol.8 (1), p.127-127, Article 127

2013

Volltextzugriff (PDF)

Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia

Journal of the American Academy of Dermatology, 2013-11, Vol.69 (5), p.839-840

2013

Volltextzugriff (PDF)

Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1

JNCI : Journal of the National Cancer Institute, 2011-11, Vol.103 (22), p.1713-1722

2011

Volltextzugriff (PDF)

mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma

Neuro-oncology (Charlottesville, Va.), 2014-04, Vol.16 (4), p.493-504

2014

Volltextzugriff (PDF)

Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis

Experimental dermatology, 2011-02, Vol.20 (2), p.107-112

2011

Volltextzugriff (PDF)

Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1

PloS one, 2014-02, Vol.9 (2), p.e85954

2014

Volltextzugriff (PDF)

The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis

Clinical cancer research, 2014-01, Vol.20 (2), p.358-371

2014

Volltextzugriff (PDF)

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis

BMC genomics, 2013-07, Vol.14 (1), p.473-473, Article 473

2013

Volltextzugriff (PDF)

Severe Cutaneous Adverse Reactions to Drugs (SCAR): Definitions, Diagnostic Criteria, Genetic Predisposition

中華皮膚科醫學雜誌, 2009-12, Vol.27 (4), p.203-209

2009

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(94)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Severe cutaneous adverse reactions to drugs

HLA‐B57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans

Therapeutic management of DRESS: A retrospective study of 38 cases

Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Patch testing in non‐immediate cutaneous adverse drug reactions: value of extemporaneous patch tests

Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns

IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis

Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study

Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis C

Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France

Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma

Rare Variations in IL36RN in Severe Adverse Drug Reactions Manifesting as Acute Generalized Exanthematous Pustulosis

Ischemic myopathy revealing systemic calciphylaxis

Prognostic value of histologic features of toxic epidermal necrolysis

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia

Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1

mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma

Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis

Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1

The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis

Severe Cutaneous Adverse Reactions to Drugs (SCAR): Definitions, Diagnostic Criteria, Genetic Predisposition

Suchergebnisse filtern